CHRNA7 and Alzheimer disease: Since specific nicotinic receptor subtypes (i.e., α7nAchR) are involved in both central cholinergic transmission, neurotransmitter release [46] as well as immune processes [47], this could speculatively constitute a possible common pathway in AD and MS.